[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global HGH Biosimilars Consumption Market Report

September 2018 | 160 pages | ID: 2E52C8786F4EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global HGH Biosimilars market for 2018-2023.

HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others

Company profiles are primarily based on public domain information including company

Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm

Over the next five years, LPI(LP Information) projects that HGH Biosimilars will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of HGH Biosimilars market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Clinical
  • Experiment
Segmentation by application:
  • Treament
  • Prevention
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Johnson & Johnson
  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Luye Pharma
  • Sigma-Tau Group
  • Fudan-Zhangjiang
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Kingond Pharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global HGH Biosimilars consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of HGH Biosimilars market by identifying its various subsegments.
  • Focuses on the key global HGH Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the HGH Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of HGH Biosimilars submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HGH Biosimilars Consumption 2013-2023
  2.1.2 HGH Biosimilars Consumption CAGR by Region
2.2 HGH Biosimilars Segment by Type
  2.2.1 Clinical
  2.2.2 Experiment
2.3 HGH Biosimilars Consumption by Type
  2.3.1 Global HGH Biosimilars Consumption Market Share by Type (2013-2018)
  2.3.2 Global HGH Biosimilars Revenue and Market Share by Type (2013-2018)
  2.3.3 Global HGH Biosimilars Sale Price by Type (2013-2018)
2.4 HGH Biosimilars Segment by Application
  2.4.1 Treament
  2.4.2 Prevention
2.5 HGH Biosimilars Consumption by Application
  2.5.1 Global HGH Biosimilars Consumption Market Share by Application (2013-2018)
  2.5.2 Global HGH Biosimilars Value and Market Share by Application (2013-2018)
  2.5.3 Global HGH Biosimilars Sale Price by Application (2013-2018)

3 GLOBAL HGH BIOSIMILARS BY PLAYERS

3.1 Global HGH Biosimilars Sales Market Share by Players
  3.1.1 Global HGH Biosimilars Sales by Players (2016-2018)
  3.1.2 Global HGH Biosimilars Sales Market Share by Players (2016-2018)
3.2 Global HGH Biosimilars Revenue Market Share by Players
  3.2.1 Global HGH Biosimilars Revenue by Players (2016-2018)
  3.2.2 Global HGH Biosimilars Revenue Market Share by Players (2016-2018)
3.3 Global HGH Biosimilars Sale Price by Players
3.4 Global HGH Biosimilars Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global HGH Biosimilars Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players HGH Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 HGH BIOSIMILARS BY REGIONS

4.1 HGH Biosimilars by Regions
  4.1.1 Global HGH Biosimilars Consumption by Regions
  4.1.2 Global HGH Biosimilars Value by Regions
4.2 Americas HGH Biosimilars Consumption Growth
4.3 APAC HGH Biosimilars Consumption Growth
4.4 Europe HGH Biosimilars Consumption Growth
4.5 Middle East & Africa HGH Biosimilars Consumption Growth

5 AMERICAS

5.1 Americas HGH Biosimilars Consumption by Countries
  5.1.1 Americas HGH Biosimilars Consumption by Countries (2013-2018)
  5.1.2 Americas HGH Biosimilars Value by Countries (2013-2018)
5.2 Americas HGH Biosimilars Consumption by Type
5.3 Americas HGH Biosimilars Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC HGH Biosimilars Consumption by Countries
  6.1.1 APAC HGH Biosimilars Consumption by Countries (2013-2018)
  6.1.2 APAC HGH Biosimilars Value by Countries (2013-2018)
6.2 APAC HGH Biosimilars Consumption by Type
6.3 APAC HGH Biosimilars Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe HGH Biosimilars by Countries
  7.1.1 Europe HGH Biosimilars Consumption by Countries (2013-2018)
  7.1.2 Europe HGH Biosimilars Value by Countries (2013-2018)
7.2 Europe HGH Biosimilars Consumption by Type
7.3 Europe HGH Biosimilars Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HGH Biosimilars by Countries
  8.1.1 Middle East & Africa HGH Biosimilars Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa HGH Biosimilars Value by Countries (2013-2018)
8.2 Middle East & Africa HGH Biosimilars Consumption by Type
8.3 Middle East & Africa HGH Biosimilars Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 HGH Biosimilars Distributors
10.3 HGH Biosimilars Customer

11 GLOBAL HGH BIOSIMILARS MARKET FORECAST

11.1 Global HGH Biosimilars Consumption Forecast (2018-2023)
11.2 Global HGH Biosimilars Forecast by Regions
  11.2.1 Global HGH Biosimilars Forecast by Regions (2018-2023)
  11.2.2 Global HGH Biosimilars Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global HGH Biosimilars Forecast by Type
11.8 Global HGH Biosimilars Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Johnson & Johnson
  12.1.1 Company Details
  12.1.2 HGH Biosimilars Product Offered
  12.1.3 Johnson & Johnson HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Johnson & Johnson News
12.2 Gilead Sciences
  12.2.1 Company Details
  12.2.2 HGH Biosimilars Product Offered
  12.2.3 Gilead Sciences HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Gilead Sciences News
12.3 Pacira
  12.3.1 Company Details
  12.3.2 HGH Biosimilars Product Offered
  12.3.3 Pacira HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pacira News
12.4 Sun Pharmaceutical
  12.4.1 Company Details
  12.4.2 HGH Biosimilars Product Offered
  12.4.3 Sun Pharmaceutical HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Sun Pharmaceutical News
12.5 Luye Pharma
  12.5.1 Company Details
  12.5.2 HGH Biosimilars Product Offered
  12.5.3 Luye Pharma HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Luye Pharma News
12.6 Sigma-Tau Group
  12.6.1 Company Details
  12.6.2 HGH Biosimilars Product Offered
  12.6.3 Sigma-Tau Group HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sigma-Tau Group News
12.7 Fudan-Zhangjiang
  12.7.1 Company Details
  12.7.2 HGH Biosimilars Product Offered
  12.7.3 Fudan-Zhangjiang HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Fudan-Zhangjiang News
12.8 Teva Pharmaceutical
  12.8.1 Company Details
  12.8.2 HGH Biosimilars Product Offered
  12.8.3 Teva Pharmaceutical HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Teva Pharmaceutical News
12.9 CSPC
  12.9.1 Company Details
  12.9.2 HGH Biosimilars Product Offered
  12.9.3 CSPC HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 CSPC News
12.10 Novartis
  12.10.1 Company Details
  12.10.2 HGH Biosimilars Product Offered
  12.10.3 Novartis HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Novartis News
12.11 Kingond Pharm

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of HGH Biosimilars
Table Product Specifications of HGH Biosimilars
Figure HGH Biosimilars Report Years Considered
Figure Market Research Methodology
Figure Global HGH Biosimilars Consumption Growth Rate 2013-2023 (Units)
Figure Global HGH Biosimilars Value Growth Rate 2013-2023 ($ Millions)
Table HGH Biosimilars Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Clinical
Table Major Players of Clinical
Figure Product Picture of Experiment
Table Major Players of Experiment
Table Global Consumption Sales by Type (2013-2018)
Table Global HGH Biosimilars Consumption Market Share by Type (2013-2018)
Figure Global HGH Biosimilars Consumption Market Share by Type (2013-2018)
Table Global HGH Biosimilars Revenue by Type (2013-2018) ($ million)
Table Global HGH Biosimilars Value Market Share by Type (2013-2018) ($ Millions)
Figure Global HGH Biosimilars Value Market Share by Type (2013-2018)
Table Global HGH Biosimilars Sale Price by Type (2013-2018)
Figure HGH Biosimilars Consumed in Treament
Figure Global HGH Biosimilars Market: Treament (2013-2018) (Units)
Figure Global HGH Biosimilars Market: Treament (2013-2018) ($ Millions)
Figure Global Treament YoY Growth ($ Millions)
Figure HGH Biosimilars Consumed in Prevention
Figure Global HGH Biosimilars Market: Prevention (2013-2018) (Units)
Figure Global HGH Biosimilars Market: Prevention (2013-2018) ($ Millions)
Figure Global Prevention YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global HGH Biosimilars Consumption Market Share by Application (2013-2018)
Figure Global HGH Biosimilars Consumption Market Share by Application (2013-2018)
Table Global HGH Biosimilars Value by Application (2013-2018)
Table Global HGH Biosimilars Value Market Share by Application (2013-2018)
Figure Global HGH Biosimilars Value Market Share by Application (2013-2018)
Table Global HGH Biosimilars Sale Price by Application (2013-2018)
Table Global HGH Biosimilars Sales by Players (2016-2018) (Units)
Table Global HGH Biosimilars Sales Market Share by Players (2016-2018)
Figure Global HGH Biosimilars Sales Market Share by Players in 2016
Figure Global HGH Biosimilars Sales Market Share by Players in 2017
Table Global HGH Biosimilars Revenue by Players (2016-2018) ($ Millions)
Table Global HGH Biosimilars Revenue Market Share by Players (2016-2018)
Figure Global HGH Biosimilars Revenue Market Share by Players in 2016
Figure Global HGH Biosimilars Revenue Market Share by Players in 2017
Table Global HGH Biosimilars Sale Price by Players (2016-2018)
Figure Global HGH Biosimilars Sale Price by Players in 2017
Table Global HGH Biosimilars Manufacturing Base Distribution and Sales Area by Players
Table Players HGH Biosimilars Products Offered
Table HGH Biosimilars Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global HGH Biosimilars Consumption by Regions 2013-2018 (Units)
Table Global HGH Biosimilars Consumption Market Share by Regions 2013-2018
Figure Global HGH Biosimilars Consumption Market Share by Regions 2013-2018
Table Global HGH Biosimilars Value by Regions 2013-2018 ($ Millions)
Table Global HGH Biosimilars Value Market Share by Regions 2013-2018
Figure Global HGH Biosimilars Value Market Share by Regions 2013-2018
Figure Americas HGH Biosimilars Consumption 2013-2018 (Units)
Figure Americas HGH Biosimilars Value 2013-2018 ($ Millions)
Figure APAC HGH Biosimilars Consumption 2013-2018 (Units)
Figure APAC HGH Biosimilars Value 2013-2018 ($ Millions)
Figure Europe HGH Biosimilars Consumption 2013-2018 (Units)
Figure Europe HGH Biosimilars Value 2013-2018 ($ Millions)
Figure Middle East & Africa HGH Biosimilars Consumption 2013-2018 (Units)
Figure Middle East & Africa HGH Biosimilars Value 2013-2018 ($ Millions)
Table Americas HGH Biosimilars Consumption by Countries (2013-2018) (Units)
Table Americas HGH Biosimilars Consumption Market Share by Countries (2013-2018)
Figure Americas HGH Biosimilars Consumption Market Share by Countries in 2017
Table Americas HGH Biosimilars Value by Countries (2013-2018) ($ Millions)
Table Americas HGH Biosimilars Value Market Share by Countries (2013-2018)
Figure Americas HGH Biosimilars Value Market Share by Countries in 2017
Table Americas HGH Biosimilars Consumption by Type (2013-2018) (Units)
Table Americas HGH Biosimilars Consumption Market Share by Type (2013-2018)
Figure Americas HGH Biosimilars Consumption Market Share by Type in 2017
Table Americas HGH Biosimilars Consumption by Application (2013-2018) (Units)
Table Americas HGH Biosimilars Consumption Market Share by Application (2013-2018)
Figure Americas HGH Biosimilars Consumption Market Share by Application in 2017
Figure United States HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure United States HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Canada HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Canada HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Mexico HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Mexico HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Table APAC HGH Biosimilars Consumption by Countries (2013-2018) (Units)
Table APAC HGH Biosimilars Consumption Market Share by Countries (2013-2018)
Figure APAC HGH Biosimilars Consumption Market Share by Countries in 2017
Table APAC HGH Biosimilars Value by Countries (2013-2018) ($ Millions)
Table APAC HGH Biosimilars Value Market Share by Countries (2013-2018)
Figure APAC HGH Biosimilars Value Market Share by Countries in 2017
Table APAC HGH Biosimilars Consumption by Type (2013-2018) (Units)
Table APAC HGH Biosimilars Consumption Market Share by Type (2013-2018)
Figure APAC HGH Biosimilars Consumption Market Share by Type in 2017
Table APAC HGH Biosimilars Consumption by Application (2013-2018) (Units)
Table APAC HGH Biosimilars Consumption Market Share by Application (2013-2018)
Figure APAC HGH Biosimilars Consumption Market Share by Application in 2017
Figure China HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure China HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Japan HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Japan HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Korea HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Korea HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Southeast Asia HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure India HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure India HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Australia HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Australia HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Table Europe HGH Biosimilars Consumption by Countries (2013-2018) (Units)
Table Europe HGH Biosimilars Consumption Market Share by Countries (2013-2018)
Figure Europe HGH Biosimilars Consumption Market Share by Countries in 2017
Table Europe HGH Biosimilars Value by Countries (2013-2018) ($ Millions)
Table Europe HGH Biosimilars Value Market Share by Countries (2013-2018)
Figure Europe HGH Biosimilars Value Market Share by Countries in 2017
Table Europe HGH Biosimilars Consumption by Type (2013-2018) (Units)
Table Europe HGH Biosimilars Consumption Market Share by Type (2013-2018)
Figure Europe HGH Biosimilars Consumption Market Share by Type in 2017
Table Europe HGH Biosimilars Consumption by Application (2013-2018) (Units)
Table Europe HGH Biosimilars Consumption Market Share by Application (2013-2018)
Figure Europe HGH Biosimilars Consumption Market Share by Application in 2017
Figure Germany HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Germany HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure France HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure France HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure UK HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure UK HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Italy HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Italy HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Russia HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Russia HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Spain HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Spain HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa HGH Biosimilars Consumption by Countries (2013-2018) (Units)
Table Middle East & Africa HGH Biosimilars Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa HGH Biosimilars Consumption Market Share by Countries in 2017
Table Middle East & Africa HGH Biosimilars Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa HGH Biosimilars Value Market Share by Countries (2013-2018)
Figure Middle East & Africa HGH Biosimilars Value Market Share by Countries in 2017
Table Middle East & Africa HGH Biosimilars Consumption by Type (2013-2018) (Units)
Table Middle East & Africa HGH Biosimilars Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa HGH Biosimilars Consumption Market Share by Type in 2017
Table Middle East & Africa HGH Biosimilars Consumption by Application (2013-2018) (Units)
Table Middle East & Africa HGH Biosimilars Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa HGH Biosimilars Consumption Market Share by Application in 2017
Figure Egypt HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Egypt HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure South Africa HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure South Africa HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Israel HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Israel HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure Turkey HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure Turkey HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Figure GCC Countries HGH Biosimilars Consumption Growth 2013-2018 (Units)
Figure GCC Countries HGH Biosimilars Value Growth 2013-2018 ($ Millions)
Table HGH Biosimilars Distributors List
Table HGH Biosimilars Customer List
Figure Global HGH Biosimilars Consumption Growth Rate Forecast (2018-2023) (Units)
Figure Global HGH Biosimilars Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global HGH Biosimilars Consumption Forecast by Countries (2018-2023) (Units)
Table Global HGH Biosimilars Consumption Market Forecast by Regions
Table Global HGH Biosimilars Value Forecast by Countries (2018-2023) ($ Millions)
Table Global HGH Biosimilars Value Market Share Forecast by Regions
Figure Americas HGH Biosimilars Consumption 2018-2023 (Units)
Figure Americas HGH Biosimilars Value 2018-2023 ($ Millions)
Figure APAC HGH Biosimilars Consumption 2018-2023 (Units)
Figure APAC HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Europe HGH Biosimilars Consumption 2018-2023 (Units)
Figure Europe HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Middle East & Africa HGH Biosimilars Consumption 2018-2023 (Units)
Figure Middle East & Africa HGH Biosimilars Value 2018-2023 ($ Millions)
Figure United States HGH Biosimilars Consumption 2018-2023 (Units)
Figure United States HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Canada HGH Biosimilars Consumption 2018-2023 (Units)
Figure Canada HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Mexico HGH Biosimilars Consumption 2018-2023 (Units)
Figure Mexico HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Brazil HGH Biosimilars Consumption 2018-2023 (Units)
Figure Brazil HGH Biosimilars Value 2018-2023 ($ Millions)
Figure China HGH Biosimilars Consumption 2018-2023 (Units)
Figure China HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Japan HGH Biosimilars Consumption 2018-2023 (Units)
Figure Japan HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Korea HGH Biosimilars Consumption 2018-2023 (Units)
Figure Korea HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Southeast Asia HGH Biosimilars Consumption 2018-2023 (Units)
Figure Southeast Asia HGH Biosimilars Value 2018-2023 ($ Millions)
Figure India HGH Biosimilars Consumption 2018-2023 (Units)
Figure India HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Australia HGH Biosimilars Consumption 2018-2023 (Units)
Figure Australia HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Germany HGH Biosimilars Consumption 2018-2023 (Units)
Figure Germany HGH Biosimilars Value 2018-2023 ($ Millions)
Figure France HGH Biosimilars Consumption 2018-2023 (Units)
Figure France HGH Biosimilars Value 2018-2023 ($ Millions)
Figure UK HGH Biosimilars Consumption 2018-2023 (Units)
Figure UK HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Italy HGH Biosimilars Consumption 2018-2023 (Units)
Figure Italy HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Russia HGH Biosimilars Consumption 2018-2023 (Units)
Figure Russia HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Spain HGH Biosimilars Consumption 2018-2023 (Units)
Figure Spain HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Egypt HGH Biosimilars Consumption 2018-2023 (Units)
Figure Egypt HGH Biosimilars Value 2018-2023 ($ Millions)
Figure South Africa HGH Biosimilars Consumption 2018-2023 (Units)
Figure South Africa HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Israel HGH Biosimilars Consumption 2018-2023 (Units)
Figure Israel HGH Biosimilars Value 2018-2023 ($ Millions)
Figure Turkey HGH Biosimilars Consumption 2018-2023 (Units)
Figure Turkey HGH Biosimilars Value 2018-2023 ($ Millions)
Figure GCC Countries HGH Biosimilars Consumption 2018-2023 (Units)
Figure GCC Countries HGH Biosimilars Value 2018-2023 ($ Millions)
Table Global HGH Biosimilars Consumption Forecast by Type (2018-2023) (Units)
Table Global HGH Biosimilars Consumption Market Share Forecast by Type (2018-2023)
Table Global HGH Biosimilars Value Forecast by Type (2018-2023) ($ Millions)
Table Global HGH Biosimilars Value Market Share Forecast by Type (2018-2023)
Table Global HGH Biosimilars Consumption Forecast by Application (2018-2023) (Units)
Table Global HGH Biosimilars Consumption Market Share Forecast by Application (2018-2023)
Table Global HGH Biosimilars Value Forecast by Application (2018-2023) ($ Millions)
Table Global HGH Biosimilars Value Market Share Forecast by Application (2018-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson HGH Biosimilars Market Share (2016-2018)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Gilead Sciences HGH Biosimilars Market Share (2016-2018)
Table Pacira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pacira HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pacira HGH Biosimilars Market Share (2016-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharmaceutical HGH Biosimilars Market Share (2016-2018)
Table Luye Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Luye Pharma HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Luye Pharma HGH Biosimilars Market Share (2016-2018)
Table Sigma-Tau Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sigma-Tau Group HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sigma-Tau Group HGH Biosimilars Market Share (2016-2018)
Table Fudan-Zhangjiang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fudan-Zhangjiang HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Fudan-Zhangjiang HGH Biosimilars Market Share (2016-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Pharmaceutical HGH Biosimilars Market Share (2016-2018)
Table CSPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSPC HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSPC HGH Biosimilars Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis HGH Biosimilars Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis HGH Biosimilars Market Share (2016-2018)
Table Kingond Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications